Institutional Ownership Vaxcyte, Inc. (PCVX)
This table provides information about the institutional ownership of Vaxcyte, Inc. (PCVX). We have compiled data on the 349 institutions that hold shares in the stock, with a total of 130 Million shares, which have been reported (via 13F filing form) to have a value of $10.7 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
11,961,687
shares
|
$986 Million
0.02% of portfolio
|
Q4 2024
Added 4.56%
|
|
|
Janus Henderson Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
10,575,363
shares
|
$872 Million
0.46% of portfolio
|
Q4 2024
Reduced 3.17%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
9,939,846
shares
|
$820 Million
0.02% of portfolio
|
Q2 2024
Added 4.49%
|
|
|
Ra Capital Management, L.P.
Boston, MA |
Feb 14, 2025 Q4 2024 |
8,689,190
shares
|
$717 Million
11.52% of portfolio
|
Q3 2024
Added 5.92%
|
|
|
Capital Research Global Investors
Los Angeles, CA |
Feb 13, 2025 Q4 2024 |
6,210,523
shares
|
$512 Million
0.11% of portfolio
|
Q4 2024
Added 26.79%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
4,539,406
shares
|
$374 Million
0.02% of portfolio
|
Q4 2024
Added 33.29%
|
|
|
Wellington Management Group LLP
Boston, MA |
Feb 12, 2025 Q4 2024 |
4,444,012
shares
|
$366 Million
0.07% of portfolio
|
Q4 2024
Reduced 1.55%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
3,966,956
shares
|
$327 Million
0.04% of portfolio
|
Q4 2024
Reduced 11.18%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
3,129,604
shares
|
$258 Million
0.04% of portfolio
|
Q4 2024
Added 229.69%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Feb 12, 2025 Q4 2024 |
2,869,332
shares
|
$237 Million
0.07% of portfolio
|
Q4 2024
Added 2.98%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
2,860,717
shares
|
$236 Million
0.14% of portfolio
|
Q4 2024
Reduced 29.43%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
2,802,888
shares
|
$231 Million
0.02% of portfolio
|
Q4 2024
Added 3.78%
|
|
|
Westfield Capital Management CO LP
Boston, MA |
Feb 11, 2025 Q4 2024 |
2,566,759
shares
|
$212 Million
0.97% of portfolio
|
Q4 2024
Added 47.53%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
Feb 14, 2025 Q4 2024 |
2,336,796
shares
|
$193 Million
12.12% of portfolio
|
Q4 2024
Added 124.85%
|
|
|
Abingworth LLP
London, X0 |
Feb 10, 2023 Q4 2022 |
2,019,057
shares
|
$167 Million
32.11% of portfolio
|
Q4 2022
Reduced 51.57%
|
|
|
Alliancebernstein L.P.
New York, NY |
Feb 12, 2025 Q4 2024 |
1,779,362
shares
|
$147 Million
0.05% of portfolio
|
Q4 2024
Added 8.11%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
1,735,663
shares
|
$143 Million
0.01% of portfolio
|
Q4 2024
Added 21.57%
|
|
|
Perceptive Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,718,417
shares
|
$142 Million
4.69% of portfolio
|
Q4 2024
Reduced 15.25%
|
|
|
Commodore Capital LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,625,000
shares
|
$134 Million
13.32% of portfolio
|
Q4 2024
Added 76.63%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,480,747
shares
|
$122 Million
0.09% of portfolio
|
Q2 2023
Added 120.98%
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,422,787
shares
|
$117 Million
4.44% of portfolio
|
Q4 2024
Added 126.66%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
1,341,773
shares
|
$111 Million
0.02% of portfolio
|
Q4 2024
Added 3.54%
|
|
|
Jennison Associates LLC
|
Jan 24, 2025 Q4 2024 |
1,246,551
shares
|
$103 Million
0.06% of portfolio
|
Q4 2024
Added 0.74%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Feb 14, 2025 Q4 2024 |
1,212,706
shares
|
$100 Million
0.04% of portfolio
|
Q4 2024
Added 5.62%
|
|
|
Lee Ainslie
Maverick Capital LTD | Dallas, Tx
|
Feb 14, 2025 Q4 2024 |
1,201,898
shares
|
$99.1 Million
1.9% of portfolio
|
Q4 2024
Added 23.11%
|